6Fu MF,Wen LT,Herng CC,et al.Quality of life as a survival predictor for esophageal sequamous cell carcinoma treated with radiotherphy[J].Int J Radiat Oncol Biol Phys,2004,58(5):1394-1404.
7Croby DL,Brewster AE,Borley A.Definitive chemoradiation in patients with inoperable esophageal carcinoma[J].Br J Cancer,2004,90(1):70-75.
8Nakagawa S,Kanda T,Kosugis S,et al.Recurrence pattern of sequamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenoctomy[J].J Am Coll Sung,2004,198(1):205-211.
3Tai P, van Dyk J, Yu E, et al. Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Bid Phys,1998,42:277-288.
4Abmad M, Nath R. Three-dimensional radiotherapy of head and neck and esophageal carcinomas: a monoisocentric treatment technique to achieve improved dose distributions. Int J Cancer,2001,96:55-65.
6Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.Int J Radiat Oncol Biol Phys,1989,16:1623-1630.
7Lyman JT.Complication probability as assessed from dose volume historgrams.Rad Res,1985,104:S13-S15.
9Bedford JL, Viviers L, Guzel Z, et al. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus. Radiother Oncol,2000, 57:183-193.
10Nutting CM, Bedford JL,Cosgrove VP,et al.A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol,2001,61:157-163.
